Lisa shared her personal metabolic protocol — not as medical advice, but to showcase alternatives to DON for glutamine inhibition, plus a detailed food/activity journal and drug sensitivity testing (Onconomics Plus by RGCC). She based her decisions on lab results to guide which drugs and nutraceuticals to include or omit. ✅ Scientific & Philosophical Insights - Focus on Press-Pulse strategy: combining glucose/glutamine inhibition, fasting, HBOT, and nutraceuticals. - Belief that cancer is a mitochondrial metabolic disease, not a genetic one. - Lisa emphasized practical implementation in the real world, not theoretical models. - Her journal tracked macros, GKI, energy, and treatment timing to optimize synergy. ✅ Practical Wisdom from Community - Egg Scrambled suggested R-ALA instead of ALA, and Pterostilbene instead of Resveratrol for better bioavailability. - Discussion on 2DG as a glucose blocker before HBOT. - Stephen Mecke recommended sulforaphane for prostate and other cancers — highlighted enzyme myrosinase importance and shared links. - Mi Mo commented on CTC trends and her own carnivore experience. - Lisa’s non-negotiables include keto macros, fasting windows, sleep schedule, and daily rebounding/earthing. ✅ Resources & References Shared - Lisa’s Onconomics Plus RGCC Report (CTC: 2.2 cells/ml). - Supplements purchased from Chemist Warehouse, iHerb, NutriNZ, Bob Harrison Dispensary, Poten-C NZ, MCSFormulas. - Research links on: • Ketogenic diet • Glutamine metabolism • ReDO protocol • Vitamin C, Quercetin, Curcumin, HBOT • Earthing, Contrast Therapy, Apoptosis markers ✅ Key Takeaways - Lisa’s protocol includes over 30 nutraceuticals, 10+ repurposed drugs, HBOT, fasting, and infrared therapy. - Glutamine inhibitors used: Fenbendazole, Sodium Phenylbutyrate, Dipyridamole, Loratadine, Ursolic Acid, Hesperidin, EGCG — as DON alternatives. - IV Vitamin C, Capecitabine, DCA, Metformin, Cimetidine, and Propranolol all included based on test sensitivity. - Daily lifestyle factors (sleep, fasting, movement, rebounder, tracking GKI) treated as core therapies, not extras. - This protocol is a strong case study in patient-led, test-informed, multi-modal metabolic therapy.